Quick Answer
Equillium, Inc. reported Common Stock Shares Outstanding of 61.46 million shares for the year ending 2025.
- Equillium, Inc. showed an increase of +72.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Equillium, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: 11.13 million shares | Q1 2019: 17.38 million shares | Q2 2019: 17.38 million shares | Q3 2019: 17.38 million shares | Q1 2020: 17.68 million shares | Q2 2020: 17.72 million shares | Q3 2020: 24.72 million shares | Q1 2021: 29.04 million shares | Q2 2021: 29.38 million shares | Q3 2021: 29.38 million shares | Q1 2022: 34.41 million shares | Q2 2022: 34.35 million shares | Q3 2022: 34.35 million shares | Q1 2023: 34.41 million shares | Q2 2023: 34.57 million shares | Q3 2023: 35.12 million shares | Q1 2024: 35.25 million shares | Q2 2024: 35.42 million shares | Q3 2024: 35.42 million shares | Q1 2025: 35.72 million shares | Q2 2025: 35.72 million shares | Q3 2025: 60.68 million shares.
- Over the full 9 years of available data (2017 to 2025), Equillium, Inc.'s Common Stock Shares Outstanding has grown by 474.0%.
- Historical annual values: Fiscal year 2025: 61.46 million shares | Fiscal year 2024: 35.56 million shares | Fiscal year 2023: 35.25 million shares | Fiscal year 2022: 34.41 million shares | Fiscal year 2021: 29.46 million shares | Fiscal year 2020: 24.75 million shares | Fiscal year 2019: 17.43 million shares | Fiscal year 2018: 17.38 million shares | Fiscal year 2017: 10.71 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: